<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">41010496</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>18</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>16</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Dietary Modifications in IBS Leads to Reduced Symptoms, Weight, and Lipid Levels: Two Randomized Clinical Trials.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2966</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu17182966</ELocationID><Abstract><AbstractText><b>Background/Objectives</b>: Irritable bowel syndrome (IBS) is presented with both gastrointestinal and extraintestinal symptoms. In addition, overweight/obesity and metabolic syndrome is prevalent in IBS. Dietary interventions with a low content of fermentable oligo-, di-, and monosaccharides and polyols (FODMAP) or a starch- and sucrose-reduced diet (SSRD) efficiently reduce symptoms and weight. Our hypothesis was that not only nutrition composition but also weight reduction is of importance for symptom relief. The aim was to merge two randomized trials and examine symptoms, weight, nutrition intake, and lipid levels at baseline and during nutritional intervention. <b>Methods</b>: One study with 105 IBS patients randomized to either an SSRD (<i>n</i> = 80) or control diet (<i>n</i> = 25) and one study with 155 IBS patients randomized to an SSRD (<i>n</i> = 77) or low FODMAP (<i>n</i> = 78) were merged. Symptom and food questionnaires were analyzed together with weight/body mass index (BMI) and lipid levels. <b>Results</b>: Patients had moderate or severe IBS at baseline, and half of them were overweight/obese. Energy intake was reduced by both diets, with the most pronounced carbohydrate reduction after the SSRD. The cholesterol levels were highest in the second cohort, possibly due to the higher fat and lower starch intake. About 25% had high-density lipoprotein below reference levels. Gastrointestinal and extraintestinal symptoms, as well as weight/BMI, were reduced by the SSRD and low FODMAP, but not in the control group. The SSRD in the second cohort and low FODMAP rendered lower levels of total cholesterol, low-density lipoprotein, and non-high-density lipoprotein levels. Weight/BMI were more often associated with lipid levels and symptoms than nutrient composition at baseline, and weight/BMI reductions correlated with carbohydrate reduction and were associated with a reduction in gastrointestinal and extraintestinal symptoms. <b>Conclusions</b>: Not only food components, but also overweight/obesity may be of importance for the development and severity of IBS and related symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roth</LastName><ForeName>Bodil</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, 22100 Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Sk&#xe5;ne University Hospital, 20502 Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohlsson</LastName><ForeName>Bodil</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-9142-5244</Identifier><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, 22100 Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Sk&#xe5;ne University Hospital, 20502 Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022-Projekt 0067</GrantID><Agency>Development Foundation of Region Sk&#xe5;ne</Agency><Country/></Grant><Grant><GrantID>2022/2023</GrantID><Agency>Foundation of Sk&#xe5;ne University Hospital</Agency><Country/></Grant><Grant><GrantID>2023</GrantID><Agency>Dir Albert P&#xe5;hlsson&#xb4;s Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009005">Monosaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C024617">polyol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004040">Dietary Carbohydrates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011108">Polymers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043183" MajorTopicYN="Y">Irritable Bowel Syndrome</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="Y">Lipids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="Y">Weight Loss</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050177" MajorTopicYN="N">Overweight</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002149" MajorTopicYN="N">Energy Intake</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009005" MajorTopicYN="N">Monosaccharides</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004038" MajorTopicYN="Y">Diet, Reducing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004040" MajorTopicYN="N">Dietary Carbohydrates</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011108" MajorTopicYN="N" AutoHM="Y">Polymers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SSRD</Keyword><Keyword MajorTopicYN="N">dietary habits</Keyword><Keyword MajorTopicYN="N">irritable bowel syndrome</Keyword><Keyword MajorTopicYN="N">lipid profile</Keyword><Keyword MajorTopicYN="N">low FODMAP</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword><Keyword MajorTopicYN="N">weight</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>27</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>27</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41010496</ArticleId><ArticleId IdType="pmc">PMC12472658</ArticleId><ArticleId IdType="doi">10.3390/nu17182966</ArticleId><ArticleId IdType="pii">nu17182966</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mearin F., Lacy B.E., Chang L., Chey W.D., Lembo A.J., Simren M., Spiller R. Bowel disorders. Gastroenterology. 2016;150:1393&#x2013;1407. doi: 10.1053/j.gastro.2016.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.02.031</ArticleId><ArticleId IdType="pubmed">27144627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperber A.D., Bangdiwala S.I., Drossman D.A., Ghoshal U.C., Simren M., Tack J., Whitehead W.E., Dumitrascu D.L., Fang X., Fukudo S., et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160:99&#x2013;114. doi: 10.1053/j.gastro.2020.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.04.014</ArticleId><ArticleId IdType="pubmed">32294476</ArticleId></ArticleIdList></Reference><Reference><Citation>Zia J.K., Lenhart A., Yang P.-L., Heitkemper M.M., Baker J., Keefer L., Saps M., Cuff C., Hungria G., Videlock E.J., et al. Risk factors for abdominal pain-related disorders of gut-brain interaction in adults and children: A systematic review. Gastroenterology. 2022;163:995&#x2013;1023. doi: 10.1053/j.gastro.2022.06.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.06.028</ArticleId><ArticleId IdType="pmc">PMC9509486</ArticleId><ArticleId IdType="pubmed">35716771</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Niu K., Momma H., Kobayashi Y., Chujo M., Otomo A., Fukudo S., Nagatomi R., Zirlik A. Irritable bowel syndrome is positively related to metabolic syndrome: A population-based cross-sectional study. PLoS ONE. 2014;9:e112289. doi: 10.1371/journal.pone.0112289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0112289</ArticleId><ArticleId IdType="pmc">PMC4226513</ArticleId><ArticleId IdType="pubmed">25383869</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M., Liu D., Tan Y., He J., Zhou B. A mendelian randomization study on the effects of plasma lipids on irritable bowel syndrome and functional dyspepsia. Sci. Rep. 2024;14:78. doi: 10.1038/s41598-023-50459-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-50459-9</ArticleId><ArticleId IdType="pmc">PMC10761668</ArticleId><ArticleId IdType="pubmed">38167458</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yang H., Song J., Chen W., Liu K., Liu B., Luo P., Sun X., He Z., Mao Y., et al. Associations of modifiable factors with risk of irritable bowel syndrome. Frontiers. 2024;11:1362615. doi: 10.3389/fnut.2024.1362615.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2024.1362615</ArticleId><ArticleId IdType="pmc">PMC11246901</ArticleId><ArticleId IdType="pubmed">39010855</ArticleId></ArticleIdList></Reference><Reference><Citation>Algera J., Colomier E., Simr&#xe9;n M. The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence. Nutrients. 2019;11:2162. doi: 10.3390/nu11092162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11092162</ArticleId><ArticleId IdType="pmc">PMC6770052</ArticleId><ArticleId IdType="pubmed">31505870</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell H., Porter J., Gibson P.R., Barrett J., Garg M. Review article: Implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research. Aliment. Pharmacol. Ther. 2019;49:124&#x2013;139. doi: 10.1111/apt.15079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.15079</ArticleId><ArticleId IdType="pubmed">30589971</ArticleId></ArticleIdList></Reference><Reference><Citation>Nybacka S., T&#xf6;rnblom H., Josefsson A., Hreinsson J.P., B&#xf6;hn L., Fr&#xe4;ndemark &#xc5;., Weznaver C., St&#xf6;rsrud S., Simr&#xe9;n M. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): A single-centre, single-blind, randomised controlled trial. Lancet Gastroenterol. Hepatol. 2024;9:507&#x2013;520. doi: 10.1016/S2468-1253(24)00045-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(24)00045-1</ArticleId><ArticleId IdType="pubmed">38643782</ArticleId></ArticleIdList></Reference><Reference><Citation>Treem W.R. Clinical aspects and treatment of congenital sucrase-isomaltase deficiency. J. Pediatr. Gastroenterol. Nutr. 2012;55((Suppl. S2)):S7&#x2013;S13. doi: 10.1097/01.mpg.0000421401.57633.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mpg.0000421401.57633.90</ArticleId><ArticleId IdType="pubmed">23103658</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen M.K., Skotte L., J&#xf8;rsboe E., Polito R., St&#xe6;ger F.F., Aldiss P., Hangh&#xf8;j K., Waples R.K., Santander C.G., Grarup N., et al. Loss of Sucrase-Isomaltase Function Increases Acetate Levels and Improves Metabolic Health in Greenlandic Cohorts. Gastroenterology. 2022;162:1171&#x2013;1182.e3. doi: 10.1053/j.gastro.2021.12.236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.12.236</ArticleId><ArticleId IdType="pubmed">34914943</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Etxebarria K., Zheng T., Bonfiglio F., Bujanda L., Dlugosz A., Lindberg G., Schmidt P.T., Karling P., Ohlsson B., Simren M., et al. Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients. Clin. Gastroenterol. Hepatol. 2018;16:1673&#x2013;1676. doi: 10.1016/j.cgh.2018.01.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2018.01.047</ArticleId><ArticleId IdType="pmc">PMC6103908</ArticleId><ArticleId IdType="pubmed">29408290</ArticleId></ArticleIdList></Reference><Reference><Citation>Henstr&#xf6;m M., Diekmann L., Bonfiglio F., Hadizadeh F., Kuech E.-M., Von K&#xf6;ckritz-Blickwede M., Thingholm L.B., Zheng T., Assadi G., Dierks C., et al. Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome. Gut. 2018;67:263&#x2013;270. doi: 10.1136/gutjnl-2016-312456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2016-312456</ArticleId><ArticleId IdType="pmc">PMC5563477</ArticleId><ArticleId IdType="pubmed">27872184</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilholm C., Roth B., Ohlsson B. A Dietary Intervention with Reduction of Starch and Sucrose Leads to Reduced Gastrointestinal and Extra-Intestinal Symptoms in IBS Patients. Nutrients. 2019;11:1662. doi: 10.3390/nu11071662.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11071662</ArticleId><ArticleId IdType="pmc">PMC6682926</ArticleId><ArticleId IdType="pubmed">31330810</ArticleId></ArticleIdList></Reference><Reference><Citation>Gayoso L., Garcia-Etxebarria K., Arzallus T., Montalvo I., Lizasoain J., D&#x2019;aMato M., Etxeberria U., Bujanda L. The effect of starch- and sucrose-reduced diet accompanied by nutritional and culinary recommendations on the symptoms of irritable bowel syndrome patients with diarrhoea. Ther. Adv. Gastroenterol. 2023;16:17562848231156682. doi: 10.1177/17562848231156682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562848231156682</ArticleId><ArticleId IdType="pmc">PMC10155021</ArticleId><ArticleId IdType="pubmed">37153501</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth B., Nseir M., Jeppsson H., D&#x2019;Amato M., Sundquist K., Ohlsson B. A starch- and sucrose-reduced diet has similar efficiency as low FODMAP in IBS. A randomized non-inferiority study. Nutrients. 2024;16:3039. doi: 10.3390/nu16173039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu16173039</ArticleId><ArticleId IdType="pmc">PMC11397485</ArticleId><ArticleId IdType="pubmed">39275354</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Shiblawi N., Cullman K., Roth B., Liljebo T., St&#xf6;rsrud S., Ohlsson B. A starch- and sucrose-reduced diet leads to a more. favorable nutrient profile than low FODMAP in patients with irritable bowel syndrome. A randomized clinical trial. Hum. Nutr. Metab. 2025;42:200337. doi: 10.1016/j.hnm.2025.200337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hnm.2025.200337</ArticleId></ArticleIdList></Reference><Reference><Citation>Body Mass Index (BMI) (who.int)  [(accessed on 1 December 2023)].  Available online:  https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/body-mass-index.</Citation></Reference><Reference><Citation>International Diabetes Federation: The IDF Consensus Worldwide Definition of the Metabolic Syndrome [Article Online]  [(accessed on 25 September 2024)].  Available online:  https://idf.org/media/uploads/2023/05/attachments-30.pdf.</Citation></Reference><Reference><Citation>Francis C.Y., Morris J., Whorwell P.J. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment. Pharmacol. Ther. 1997;11:395&#x2013;402. doi: 10.1046/j.1365-2036.1997.142318000.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2036.1997.142318000.x</ArticleId><ArticleId IdType="pubmed">9146781</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth B., Ohlsson B. Challenges of recruitment processes to a randomized dietary trial in irritable bowel syndrome. F1000Research. 2024;13:323. doi: 10.12688/f1000research.147710.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.147710.2</ArticleId><ArticleId IdType="pmc">PMC11208853</ArticleId><ArticleId IdType="pubmed">38939366</ArticleId></ArticleIdList></Reference><Reference><Citation>ICD-10  Version:2019 (who.int)  [(accessed on 12 May 2024)].  Available online:  https://icd.who.int/browse10/2019/en.</Citation></Reference><Reference><Citation>Choosing Your Foods. CSID Cares.  [(accessed on 12 February 2024)].  Available online:  https://www.csidcares.org.</Citation></Reference><Reference><Citation>Whelan K., Martin L.D., Staudacher H.M., Lomer M.C.E. The low FODMAP diet in the management of irritable bowel syndrome: An evidence-based review of FODMAP restriction, reintroduction and personalization in clinical practice. J. Hum. Nutr. Diet. 2018;31:239&#x2013;255. doi: 10.1111/jhn.12530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jhn.12530</ArticleId><ArticleId IdType="pubmed">29336079</ArticleId></ArticleIdList></Reference><Reference><Citation>Staudacher H.M., Ralph F.S.E., Irving P.M., Whelan K., Lomer M.C.E. Nutrient intake, diet quality, and diet diversity in irritable bowel syndrome and the impact of the low FODMAP diet. J. Acad. Nutr. Diet. 2020;120:535&#x2013;547. doi: 10.1016/j.jand.2019.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jand.2019.01.017</ArticleId><ArticleId IdType="pubmed">31029650</ArticleId></ArticleIdList></Reference><Reference><Citation>Staudacher H.M., Rossi M., Kaminski T., Dimidi E., Ralph F.S.E., Wilson B., Martin L.D., Louis P., Lomer M.C., Irving P.M., et al. Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterol. Motil. 2022;34:e14241. doi: 10.1111/nmo.14241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.14241</ArticleId><ArticleId IdType="pubmed">34431172</ArticleId></ArticleIdList></Reference><Reference><Citation> [(accessed on 11 September 2025)].  Available online:  https://www.kostochnaring.se/aktuellt/event/kostdagarna2022/mashie-foodtech/</Citation></Reference><Reference><Citation> [(accessed on 3 April 2020)].  Available online:  www.livsmedelsverket.se.</Citation></Reference><Reference><Citation>Palsson O.S., Whitehead W.E., van Tilburg M.A., Chang L., Chey W., Crowell M.D., Keefer L., Lembo A.J., Parkman H.P., Rao S.S., et al. Development and validation of the Rome IV diagnostic questionnaire for adults. Gastroenterology. 2016;150:1481&#x2013;1491. doi: 10.1053/j.gastro.2016.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.02.014</ArticleId><ArticleId IdType="pubmed">27144634</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson M., Ohlsson B., Ulander K. Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS) BMC Gastroenterol. 2007;7:16. doi: 10.1186/1471-230X-7-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-230X-7-16</ArticleId><ArticleId IdType="pmc">PMC1868742</ArticleId><ArticleId IdType="pubmed">17475020</ArticleId></ArticleIdList></Reference><Reference><Citation>Bengtsson M., Persson J., Sj&#xf6;lund K., Ohlsson B. Further validation of the visual analogue scale for irritable bowel syndrome after use in clinical practice. Gastroenterol. Nurs. 2013;36:188&#x2013;198. doi: 10.1097/SGA.0b013e3182945881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SGA.0b013e3182945881</ArticleId><ArticleId IdType="pubmed">23732784</ArticleId></ArticleIdList></Reference><Reference><Citation>Laboratoriemedicin.  [(accessed on 12 April 2021)].  Available online:  http://www.analysportalen-labmedicin.skane.se.</Citation></Reference><Reference><Citation>McDonald J.H. Handbook of Biological Statistics. 3rd ed. Sparky House Publishing; Baltimore, MD, USA: 2014.</Citation></Reference><Reference><Citation>Schneck A.S., Anty R., Tran A., Hastier A., Ben Amor I., Gugenheim J., Iannelli A., Piche T. Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French Morbidly Obese Patients Candidate for Bariatric Surgery. Obes. Surg. 2016;26:1525&#x2013;1530. doi: 10.1007/s11695-015-1907-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-015-1907-0</ArticleId><ArticleId IdType="pubmed">26424705</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchoucha M., Fysekidis M., Julia C., Airinei G., Catheline J.-M., Reach G., Benamouzig R. Functional Gastrointestinal Disorders in Obese Patients. The Importance of the Enrollment Source. Obes. Surg. 2015;25:2143&#x2013;2152. doi: 10.1007/s11695-015-1679-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-015-1679-6</ArticleId><ArticleId IdType="pubmed">25904236</ArticleId></ArticleIdList></Reference><Reference><Citation>Steckhan N., Hohmann C.D., Kessler C., Dobos G., Michalsen A., Cramer H. Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: A systematic review and meta-analysis. Nutrition. 2016;32:338&#x2013;348. doi: 10.1016/j.nut.2015.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2015.09.010</ArticleId><ArticleId IdType="pubmed">26706026</ArticleId></ArticleIdList></Reference><Reference><Citation>Navratilova H.F., Lanham-New S., Whetton A.D., Geifman N. Associations of Diet with Health Outcomes in the UK Biobank: A Systematic Review. Nutrients. 2024;16:523. doi: 10.3390/nu16040523.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu16040523</ArticleId><ArticleId IdType="pmc">PMC10892867</ArticleId><ArticleId IdType="pubmed">38398847</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashashati M., Rezaei N., Bashashati H., Shafieyoun A., Daryani N.E., Sharkey K.A., Storr M. Cytokine gene polymorphisms are associated with irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol. Motil. 2012;24:1102-e566. doi: 10.1111/j.1365-2982.2012.01990.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2982.2012.01990.x</ArticleId><ArticleId IdType="pubmed">22897390</ArticleId></ArticleIdList></Reference><Reference><Citation>Trayhurn P., Wood I.S. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr. 2004;92:347&#x2013;355. doi: 10.1079/BJN20041213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1079/BJN20041213</ArticleId><ArticleId IdType="pubmed">15469638</ArticleId></ArticleIdList></Reference><Reference><Citation>Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2010;316:129&#x2013;139. doi: 10.1016/j.mce.2009.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2009.08.018</ArticleId><ArticleId IdType="pubmed">19723556</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson B., Hammarstedt A., Andersson C.X., Smith U. Inflamed adipose tissue: A culprit underlying the metabolic syndrome and atherosclerosis. Arter. Thromb. Vasc. Biol. 2007;27:2276&#x2013;2283. doi: 10.1161/ATVBAHA.107.147835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.107.147835</ArticleId><ArticleId IdType="pubmed">17823366</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely A., Nseir M., Roth B., Ohlsson B. Leptin and PAI-1 levels are decreased after a dietary intervention in patients with irritable bowel syndrome. Int. J. Mol. Sci. 2025;26:4607. doi: 10.3390/ijms26104607.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms26104607</ArticleId><ArticleId IdType="pmc">PMC12111115</ArticleId><ArticleId IdType="pubmed">40429752</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Chen Z., Chen B., Li J., Yuan X., Li J., Wang W., Dai T., Chen H., Wang Y., et al. Dietary sugar consumption and health: Umbrella review. BMJ. 2023;381:e071609. doi: 10.1136/bmj-2022-071609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071609</ArticleId><ArticleId IdType="pmc">PMC10074550</ArticleId><ArticleId IdType="pubmed">37019448</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques A.M., Linhares B.S., Dias Novaes R., Freitas M.B., Sarandy M.M., Gon&#xe7;alves R.V. Effects of the amount and type of carbohydrates used in type 2 diabetes diets in animal models: A systematic review. PLoS ONE. 2020;15:e0233364. doi: 10.1371/journal.pone.0233364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0233364</ArticleId><ArticleId IdType="pmc">PMC7292416</ArticleId><ArticleId IdType="pubmed">32530969</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Yang Z., Liu S., Zhang Q., Zhang S., Zhu S. Ultra-Processed Food Consumption and Long-Term Risk of Irritable Bowel Syndrome: A Large-Scale Prospective Cohort Study. Clin. Gastroenterol. Hepatol. 2024;22:1497&#x2013;1507.e5. doi: 10.1016/j.cgh.2024.01.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2024.01.040</ArticleId><ArticleId IdType="pubmed">38522476</ArticleId></ArticleIdList></Reference><Reference><Citation>Shai I., Schwarzfuchs D., Henkin Y., Shahar D.R., Witkow S., Greenberg I., Golan R., Fraser D., Bolotin A., Vardi H., et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N. Engl. J. Med. 2008;359:229&#x2013;241. doi: 10.1056/NEJMoa0708681. Erratum in N. Engl. J. Med. 2009, 361, 2681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0708681</ArticleId><ArticleId IdType="pubmed">18635428</ArticleId></ArticleIdList></Reference><Reference><Citation>Forouhi N.G., Sharp S.J., Du H., van der A D.L., Halkjaer J., Schulze M.B., Tj&#xf8;nneland A., Overvad K., Jakobsen M.U., Boeing H., et al. Dietary fat intake and subsequent weight change in adults: Results from the European Prospective Investigation into Cancer and Nutrition cohorts. Am. J. Clin. Nutr. 2009;90:1632&#x2013;1641. doi: 10.3945/ajcn.2009.27828.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.2009.27828</ArticleId><ArticleId IdType="pubmed">19828709</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto Y., Fukuda T., Oyabu C., Tanaka M., Asano M., Yamazaki M., Fukui M. Impact of low-carbohydrate diet on body composition: Meta-analysis of randomized controlled studies. Obes. Rev. 2016;17:499&#x2013;509. doi: 10.1111/obr.12405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.12405</ArticleId><ArticleId IdType="pubmed">27059106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge L., Sadeghirad B., Ball G.D.C., da Costa B.R., Hitchcock C.L., Svendrovski A., Kiflen R., Quadri K., Kwon H.Y., Karamouzian M., et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: Systematic review and network meta-analysis of randomised trials. BMJ. 2020;369:m696. doi: 10.1136/bmj.m696. Erratum in BMJ 2020, 370, m3095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m696</ArticleId><ArticleId IdType="pmc">PMC7190064</ArticleId><ArticleId IdType="pubmed">32238384</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zuuren E.J., Fedorowicz Z., Kuijpers T., Pijl H. Effects of low-carbohydrate- compared with low-fat-diet interventions on metabolic control in people with type 2 diabetes: A systematic review including GRADE assessments. Am. J. Clin. Nutr. 2018;108:300&#x2013;331. doi: 10.1093/ajcn/nqy096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/nqy096</ArticleId><ArticleId IdType="pubmed">30007275</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme P.A., Marot L.P., Nogueira L.F.R., Marqueze E.C., Crispim C.A., Moreno C.R.C. A Nutritional Counseling Program Prevents an Increase in Workers&#x2019; Dietary Intake and Body Weight During the COVID-19 Pandemic. Front. Physiol. 2021;12:703862. doi: 10.3389/fphys.2021.703862.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.703862</ArticleId><ArticleId IdType="pmc">PMC8335487</ArticleId><ArticleId IdType="pubmed">34366892</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>